Navigation Links
Vanda Pharmaceuticals Reports Second Quarter 2009 Results
Date:8/10/2009

---------- ---------- Net cash provided by (used in) investing activities (4,706,182) 41,774,374 ---------- ---------- Cash flows from financing activities: Proceeds from exercise of stock options and warrants 882,843 - ------- ------- Net cash provided by financing activities 882,843 - ------- ------- Effect of foreign currency translation - 16,745 ------- ------ Net change in cash and cash equivalents (15,065,101) 14,574,282 Cash and cash equivalents, beginning of period 39,079,304 41,929,533 ---------- ---------- Cash and cash equivalents, end of period $24,014,203 $56,503,815 =========== =========== Supplemental disclosure of non-cash investing activities Intangible asset acquisition included in accounts payable $5,000,000 -


'/>"/>
SOURCE Vanda Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
2. Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
3. LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
4. Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
5. Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights
6. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
7. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results
8. Vanda Pharmaceuticals Reports First Quarter 2009 Results
9. Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting
10. Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009
11. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 29, 2015  AACC, a global scientific and ... laboratory medicine, is pleased to announce that the ... , has increased to 7.9 in the 2014 ... Clinical Chemistry in the top 3% ... influence of the research it publishes on laboratory ...
(Date:6/29/2015)... FRANCISCO, Calif. , June 29, 2015   ... diagnostics company pioneering the field of molecular cytology, today ... Area News Group,s prestigious Top Workplaces list for the ... Top Workplace winners based solely on an annual survey ... humbled and honored that the degree to which Veracyte ...
(Date:6/26/2015)... June 26, 2015 /PRNewswire/ - iCo Therapeutics ("iCo" or ... that all nominees listed in the management information ... its 2015 Annual Meeting of Shareholders, held earlier ... ballot, the following 5 nominees proposed by management ... serve until the Company,s next Annual Meeting of ...
(Date:6/26/2015)... 23, 2015 Research ... of the "Global Cancer Biosimilars Market Opportunity ... Market introduction of cancer biosimilar is required because ... Chemotherapeutic drugs have dominated the cancer segment for ... introduced in past few years. They are biologic ...
Breaking Biology Technology:AACC's Journal, Clinical Chemistry, Continues to Have Significant Impact on Medical Testing, Healthcare 2AACC's Journal, Clinical Chemistry, Continues to Have Significant Impact on Medical Testing, Healthcare 3Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area 2Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area 3iCo Therapeutics Announces Voting & Election Results from Annual Meeting of Shareholders 2iCo Therapeutics Announces Voting & Election Results from Annual Meeting of Shareholders 3Global Cancer Biosimilars Market Opportunity Outlook 2Global Cancer Biosimilars Market Opportunity Outlook 3
... Those who attended the BIO2003 Conference in Washington D.C. ... experience. First, it was attended by over 16,000 people ... filled with dignitaries such as President Bush, Secretary Tommy ... though, the conference showcased the efforts of research scientist ...
... freeze budget proposal? Legislative Republicans voted for it because they ... convinced the freeze was good policy and secretly hoped Doyle ... Democrats and Gov. Jim Doyles proposal to raise the state ... vote for such a populist bill if it reaches the ...
... Reviving the Economy , ,* * * * * * ... from last week's DEMOmobile 2003, and the experience has only strengthened ... the overall economy. The energy from the 400-plus attendees and 37 ... crystal clear: True connectivity -- both in our homes and our ...
Cached Biology Technology:Let's Get Serious 2Doyle and the Legislature Have Much To Agree Upon When It Comes To The Economy 2Doyle and the Legislature Have Much To Agree Upon When It Comes To The Economy 3The News From DEMOmobile 2003 2The News From DEMOmobile 2003 3
(Date:6/25/2015)... According to a new ... Area), Technology, Material (Optical Prism, Piezoelectric, Capacitive & ... Others) & Geography - Global Forecast to 2014 ... is expected to reach $14,500.07 Million by 2020, ... Browse 76 market Tables and 109 Figures spread ...
(Date:6/24/2015)... , June 24, 2015  Synaptics Inc. ... human interface solutions, today announced that Sharp has ... provide secure authentication for its latest flagship smartphone ... more than 200 million shipments of its fingerprint ... reinforces Synaptics, strength, scalability and leadership in the ...
(Date:6/23/2015)...   Valencell, a leader in performance ... recent study that illustrates its PerformTek biometric technology ... In a study conducted at Valencell,s Biometric Lab, ... Apple Watch against a chest strap – the ... The study demonstrated that Valencell,s biometric technology delivers ...
Breaking Biology News(10 mins):Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... is an inherited eye disorder characterized by progressive loss ... blindness at the end stage. , In a ChIP-Seq ... of the transcription factor Crx (Cone-rod homeobox) in the ... genetic basis for visual perception. In-depth analysis of Crx ...
... ATLANTA, Ga. Nov. 18, 2010 The 2010 Golf ... to benefit research aimed at finding better treatments and eventually ... 124 players Oct. 15, 2010, to the Crabapple Golf Club ... support the Translational Genomics Research Institute (TGen), a non-profit biomedical ...
... mysterious link between bones of an ancient lizard found in ... the Komodo dragon, half a world away in Indonesia. ... shape of the vertebrae links the 33-million-year-old African lizard fossil ... for some 700,000 years. , "The African fossil was ...
Cached Biology News:Transcription factor scan identifies genetic cause for inherited blindness 2Golf Atlanta charity tournament raises $105,000 for TGen research 2Researchers link an African lizard fossil in Africa with the Komodo dragon in Indonesia 2
... PTOs are internucleotide modifications, where one ... replaced by a sulphur atom. This modification ... are available as Full-PTOs ... with thio-caps Several internucleotide ...
... The VARIOKLAV 75 S and 135 S steam ... double bottoms combine the advantages of a double-walled ... use, effective deaeration and drying by built-in jacket ... - fast cooling. The chamber is free of ...
Request Info...
... catalyzes the transfer of the gamma-phosphate ... single- and double-stranded DNA, RNA, and ... the 3'-phosphate from 3'-phosphoryl polynucleotides, deoxyribonucleoside ... form a 3'-hydroxyl group. Storage Buffer: ...
Biology Products: